Space radiation concerns for manned exploration.

Spaceflight exposes astronaut crews to natural ionizing radiation. To date, exposures in manned spaceflight have been well below the career limits recommended to NASA by the National Council of Radiation Protection and Measurements (NCRP). This will not be the case for long-duration exploratory class missions. Additionally. International Space Station (ISS) crews will receive higher doses than earlier flight crews. Uncertainties in our understanding of long-term bioeffects, as well as updated analyses of the Hiroshima. Nagasaki and Chernobyl tumorigenesis data, have prompted the NCRP to recommend further reductions by 30-50% for career dose limit guidelines. Intelligent spacecraft design and material selection can provide a shielding strategy capable of maintaining crew exposures within recommended guidelines. Current studies on newer radioprotectant compounds may find combinations of agents which further diminish the risk of radiation-induced bioeffects to the crew.

[1]  V. Shurshakov,et al.  Measurements of the linear energy transfer spectra on the Mir orbital station and comparison with radiation transport models. , 1996, Radiation measurements.

[2]  E. J. Ainsworth,et al.  High-LET radiation carcinogenesis. , 1985 .

[3]  Charles E. Swenberg,et al.  Terrestrial Space Radiation and Its Biological Effects , 1989, Nato ASI Series.

[4]  L. Kohlmeier,et al.  Dietary modifiers of carcinogenesis. , 1995, Environmental health perspectives.

[5]  A. Jursa,et al.  Handbook of geophysics and the space environment , 1985 .

[6]  V. Steele,et al.  Screening of potential chemopreventive agents using biochemical markers of carcinogenesis. , 1994, Cancer research.

[7]  W. K. Sinclair Radiation safety standards: space hazards vs. terrestrial hazards. , 1983, Advances in space research : the official journal of the Committee on Space Research.

[8]  V. Steele,et al.  Mechanistic considerations in chemopreventive drug development , 1994, Journal of cellular biochemistry. Supplement.

[9]  J. V. Bailey Dosimetry during Space Missions , 1976, IEEE Transactions on Nuclear Science.

[10]  R. Veech,et al.  Use of DHEA in a patient with advanced prostate cancer: a case report and review. , 1997, Urology.

[11]  Lawrence W. Townsend,et al.  Radiation exposure for manned Mars surface missions , 1990 .

[12]  I. Parada,et al.  Ultrastructural studies on the intracellular fate of 125I‐nerve growth factor in cultured rat sympathetic neurons , 1982, Journal of cellular biochemistry.

[13]  L. Crofford Eicosanoids and Other Bioactive Lipids , 2000 .

[14]  D. Mirkin Space Physiology and Medicine , 1990 .

[15]  M. Stanford,et al.  Implications of the New Radiation Exposure Limits on Space Station Freedom Crews , 1990 .